Pfizer Inc. to expand tobacco control efforts in China by granting US$850,000


Georgia State University’s School of Public Health has been granted nearly US$850,000 by Pfizer Inc. to partner with Chinese health officials to expand tobacco control efforts to major cities in China. The grant will support work with officials to develop policies and programs to protect non-smokers from second-hand smoke, encourage smokers to quit and prevent women, children and young adults from starting smoking. The project will be led by Dr. Michael Eriksen, Dean of the School of Public Health; Pam Redmon, Executive Director of the China Tobacco Control Partnership and Administrative Director of the School of Public Health’s Tobacco Center of Regulatory Science; and Dr. Jeffrey Koplan, Vice President for global health at Emory University and former Director of the Centers for Disease Control and Prevention.

China produces more tobacco and has more smokers than any other country in the world. In recent years, Chinese officials have shown interest in regulating tobacco use, but more can be done to put sufficient policies and programs in place to curb smoking and protect non-smokers from secondhand smoke. Studies have shown that targeting tobacco control efforts at the municipal level can be an effective approach in China, which has more than 160 cities with populations exceeding one million. The grant builds on tobacco control work conducted in China by a team of researchers from Georgia State and Emory that was previously funded by the Bill and Melinda Gates Foundation.

The new project, Diffusion of Tobacco Control Fundamentals to Other Large Chinese Cities, will expand the Tobacco Free Cities work through partnerships with China’s National Health and Family Planning Commission (formerly the Ministry of Health), ThinkTank Research Center for Health Development, a non-governmental group based in Beijing, and the China CDC. Researchers will work with cities whose leaders demonstrate readiness to support tobacco control efforts and select public health organizations positioned to lead the efforts.

This article is based on materials provided by:

Disclaimer: This articles does not reflect any personal views of the authors/editors

Previous articleTrying to remember something? Just close your eyes and try to recall
Next articleScientists find a way to prevent development of type 1 diabetes in mouse models
Scientist-entrepreneur-manager-journalist: -Co-founder, Author; Former Assistant Editor and Director, Biotechin.Asia, Biotech Media Pte. Ltd.; -Founder & CEO, SciGlo (; -Programme Management Officer, SBIC, A*STAR (former Research Fellow). --Sandhya graduated from University of Madras, India (B.Sc Microbiology and M.Sc Biotechnology) and received her Ph.D from the Nanyang Technological University, Singapore. She worked on oxidative stress in skin, skeletal, adipose tissue and cardiac muscle for a decade from 2006-2016. She is currently working as a Programme Management Officer handling projects and grants at Singapore Bioimaging Consortium (SBIC), Agency for Science, Technology and Research (A*STAR). Earlier to this she was a Research Fellow in the Fat Metabolism and Stem Cell Group at SBIC. Sandhya was also the Vice President and Publicity Chair of A*PECSS (A*STAR Post Doc Society) (2014-2016). Recently she founded a platform for scientists - SciGlo ( and is a startup mentor at Vertical VC (Finland). She is an ardent lover of science and enjoys globe trotting and good vegetarian food.